HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seigo Iwakawa Selected Research

Deoxycytidine Kinase

11/2021Combination of azacytidine and curcumin is a potential alternative in decitabine-resistant colorectal cancer cells with attenuated deoxycytidine kinase.
2/2020Numerical analysis of apparent decitabine uptake in HCT116 cells: Incorporation of a bidirectional first-order kinetic parameter for ENT1 transport and Michaelis-Menten parameters for subsequent phosphorylation.
12/2017Monophosphorylation by deoxycytidine kinase affects apparent cellular uptake of decitabine in HCT116 colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seigo Iwakawa Research Topics

Disease

11Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 05/2009
7Neoplasms (Cancer)
11/2021 - 08/2008
4Colonic Neoplasms (Colon Cancer)
12/2017 - 01/2012
2Type 2 Diabetes Mellitus (MODY)
06/2017 - 03/2017
1Neoplasm Metastasis (Metastasis)
01/2015
1Neutropenia
05/2009
1Breast Neoplasms (Breast Cancer)
08/2008
1Renal Cell Carcinoma (Grawitz Tumor)
05/2006
1Carcinoma (Carcinomatosis)
07/2004

Drug/Important Bio-Agent (IBA)

7DecitabineFDA Link
11/2021 - 01/2012
7Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2021 - 05/2009
6A-Form DNA (A-DNA)IBA
11/2021 - 01/2012
6MethyltransferasesIBA
11/2021 - 01/2012
3Pharmaceutical PreparationsIBA
11/2021 - 01/2012
3Deoxycytidine KinaseIBA
11/2021 - 12/2017
3Fluorouracil (Carac)FDA LinkGeneric
01/2015 - 05/2009
2Equilibrative Nucleoside Transporter 1IBA
02/2020 - 12/2017
2MicroRNAs (MicroRNA)IBA
08/2017 - 01/2015
2AlbuminsIBA
06/2017 - 03/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2015 - 01/2014
2Irinotecan (Camptosar)FDA LinkGeneric
01/2015 - 01/2014
2Histone Deacetylase InhibitorsIBA
01/2014 - 01/2012
1PolyphenolsIBA
11/2021
1Azacitidine (5 Azacytidine)FDA Link
11/2021
1EnzymesIBA
11/2021
1CurcuminIBA
11/2021
1Cytidine DeaminaseIBA
11/2021
1Biomarkers (Surrogate Marker)IBA
07/2021
1NucleosidesIBA
12/2017
1pyrimidin-2-one beta-ribofuranosideIBA
08/2017
1alogliptinIBA
06/2017
1Dipeptidyl-Peptidase IV InhibitorsIBA
06/2017
1GemcitabineFDA Link
08/2015
1UridineIBA
01/2015
1Histone Deacetylases (Histone Deacetylase)IBA
01/2014
1trichostatin A (A 300)IBA
01/2012
1Histones (Histone)IBA
01/2012
1Messenger RNA (mRNA)IBA
01/2012
1theasinensin AIBA
01/2012
1Leucovorin (Folinic Acid)FDA Link
05/2009
1Phospholipids (Phosphatides)FDA LinkGeneric
08/2008
1ProstaglandinsIBA
08/2008
1LipoxygenasesIBA
08/2008
1Soybean OilFDA LinkGeneric
08/2008
1LipidsIBA
08/2008
1Triglycerides (Triacylglycerol)IBA
08/2008
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
08/2008
1EicosanoidsIBA
08/2008
1Fish OilsIBA
08/2008
1EmulsionsIBA
08/2008
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
08/2008
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
05/2006
1Buthionine SulfoximineIBA
05/2006
12-MethoxyestradiolIBA
05/2006
1Mercaptoethanol (2 Mercaptoethanol)IBA
05/2006
1rhinacanthin-CIBA
07/2004

Therapy/Procedure

3Drug Therapy (Chemotherapy)
07/2021 - 05/2009
2Glycemic Control
06/2017 - 03/2017
1Therapeutics
01/2019
1Drug Tapering
05/2009